Glaucoma Surgery Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Glaucoma Surgery Devices Pipeline Market Report Overview

Glaucoma surgery devices are used to augment normal physiologic aqueous outflow pathways to provide effective intra-ocular pressure. Glaucoma drainage devices are designed to divert aqueous humor from the anterior chamber to an external reservoir, where a fibrous capsule forms about 4-6 weeks after surgery and regulates flow.

The Glaucoma Surgery Devices pipeline market research report provides comprehensive information about the Glaucoma surgery devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.

Key Segments ·        Glaucoma Drainage Devices

·        Minimally Invasive Glaucoma Surgery (MIGS) Devices

Key Territories ·        The US

·        Europe

·        China

·        South Africa

·        South Korea

·        Israel

·        Canada

·        Germany

Key Regulatory Paths ·        PMA

·        510(k)

·        CE

·        NMPA

·        MDL

·        NIFDS

Leading Companies ·        Alievio Inc

·        Allergan Ltd

·        Assenti, LLC

·        Avisi Technologies LLC

·        Chongqing Migos Medical Technology Co Ltd

·        Ciliatech Therapeutics AG

·        Corneat Vision Ltd

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Glaucoma Surgery Devices Pipeline Market by Segments

The key segments in the Glaucoma surgery devices pipeline market are Glaucoma drainage devices and Minimally Invasive Glaucoma Surgery (MIGS) Devices. As of September 2023, Glaucoma drainage devices have the most pipeline products. They are small plastic devices that are surgically attached to the eye’s surface to improve or shunt the flow of aqueous drainage. They can be further divided into valved drainage devices and non-valved drainage devices.

Glaucoma Surgery Devices Pipeline Market Analysis by Segments, 2023 (%)

Glaucoma Surgery Devices Pipeline Market Analysis by Segments, 2023 (%)

Buy Full Report for More Segment Insights into the Glaucoma Surgery Devices Pipeline Market

Download A Free Report Sample

Glaucoma Surgery Devices Pipeline Market Segmentation by Territories

Some of the key territories in the Glaucoma surgery devices market are the US, Europe, China, South Africa, South Korea, Israel, Canada, and Germany. As of September 2023, the US has the highest number of pipeline products.

Glaucoma Surgery Devices Pipeline Market Analysis by Territories, 2023 (%)

Glaucoma Surgery Devices Pipeline Market Analysis by Territories, 2023 (%)

Buy Full Report for More Territory Insights into the Glaucoma Surgery Devices Pipeline Market

Download A Free Report Sample

Glaucoma Surgery Devices Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the Glaucoma surgery devices pipeline market are PMA, 510(k), CE, NMPA, MDL, and NIFDS. As of September 2023, PMA is the most followed pathway for pipeline products in the market.

Glaucoma Surgery Devices Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Glaucoma Surgery Devices Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy Full Report for More Regulatory Path Insights into the Glaucoma Surgery Devices Pipeline Market

Download A Free Report Sample

Glaucoma Surgery Devices Pipeline Market – Competitive Landscape

Some of the key companies in the Glaucoma surgery devices pipeline market are Alievio Inc, Allergan Ltd, Assenti, LLC, Avisi Technologies LLC, Chongqing Migos Medical Technology Co Ltd, Ciliatech Therapeutics AG, and Corneat Vision Ltd.

Alievio Inc: It is an innovative glaucoma medical device company that is developing the first personalized glaucoma treatment to stop vision loss. The company is headquartered in the United States.

Allergan Ltd: It is a specialty pharmaceutical company that develops and markets branded pharmaceuticals and biosimilar and over-the-counter (OTC) pharmaceutical products. The company sells its products to retailers, drug wholesalers, and distributors, hospitals, clinics, government agencies, and managed healthcare providers. It has operations across the Americas, Europe, Asia-Pacific, the Middle East, and Africa. Allergan is headquartered in Dublin, Ireland.

Glaucoma Surgery Devices Pipeline Market Analysis by Companies, 2023

Glaucoma Surgery Devices Pipeline Market Analysis by Companies, 2023

Buy Full Report for More Company Insights into the Glaucoma Surgery Devices Pipeline Market

Download A Free Report Sample

Segments Covered in the Report

Glaucoma Surgery Devices Pipeline Market Segments Outlook

  • Glaucoma Drainage Devices
    • Valved Drainage Devices
    • Non-Valved Drainage Devices
  • Minimally Invasive Glaucoma Surgery (MIGS) Devices

Glaucoma Surgery Devices Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • South Africa
  • South Korea
  • Israel
  • Canada
  • Germany

Glaucoma Surgery Devices Pipeline Market Regulatory Paths Outlook

  • PMA
  • 510(k)
  • CE
  • NMPA
  • MDL
  • NIFDS

Scope

This report provides:

  • Extensive coverage of the Glaucoma Surgery Devices under development.
  • Details of major pipeline products which include product description, licensing and collaboration details and other developmental activities.
  • Reviews of major players involved in the development of Glaucoma surgery devices and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Provides key clinical trial data related to ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Glaucoma Surgery Devices under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Alievio Inc
Allergan Ltd
Assenti, LLC
Avisi Technologies LLC
Chongqing Migos Medical Technology Co Ltd
Ciliatech Therapeutics AG
Corneat Vision Ltd
Eye Sonix
Galaxy Ophthalmics Inc (Inactive)
Geuder AG
Glaucot Teknoloji AS
Glaukos Corp
HiSilicon (Suzhou) Biomedical Technology Co Ltd
Iantrek Inc
InjectSense Inc
InnFocus Inc
iScience Interventional Inc
iSTAR Medical SA
iVeena Delivery Systems Inc
Johns Hopkins University
Kytogenics Pharmaceuticals Inc
Liqid Medical (Pty) Ltd
Medtronic Plc
Meir Medical Center
Merz Anteis SA
MicroOptx Inc
Mingche Biotechnology (Suzhou) Co Ltd
Myra Vision Inc
Ocumatrx
OcuTherix Inc
OPKO Health Inc
OptoLight Vision Technology
Purdue University
Queen's University
Rheon Medical SA
Sight Sciences Inc
Tel Aviv University
The Chaim Sheba Medical Center
University of Colorado
University of Colorado Anschutz Medical Campus
University of Michigan
University of Texas at Austin
Westhouse Medical Services Plc (Inactive)

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 6

|1.2 List of Figures 10

2 Introduction 11

2.1 Glaucoma Surgery Devices Overview 11

3 Products under Development 12

3.1 Glaucoma Surgery Devices – Pipeline Products by Stage of Development 12

3.2 Glaucoma Surgery Devices – Pipeline Products by Segment 13

3.3 Glaucoma Surgery Devices – Pipeline Products by Territory 14

3.4 Glaucoma Surgery Devices – Pipeline Products by Regulatory Path 15

3.5 Glaucoma Surgery Devices – Pipeline Products by Estimated Approval Date 16

3.6 Glaucoma Surgery Devices – Ongoing Clinical Trials 17

4 Glaucoma Surgery Devices – Pipeline Products under Development by Companies 18

4.1 Glaucoma Surgery Devices Companies – Pipeline Products by Stage of Development 18

4.2 Glaucoma Surgery Devices – Pipeline Products by Stage of Development 20

5 Glaucoma Surgery Devices Companies and Product Overview 22

5.1 Alievio Inc Company Overview 22

5.1.1 Alievio Inc Pipeline Products & Ongoing Clinical Trials Overview 22

5.2 Allergan Ltd Company Overview 23

5.2.1 Allergan Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

5.3 Assenti, LLC Company Overview 24

5.3.1 Assenti, LLC Pipeline Products & Ongoing Clinical Trials Overview 24

5.4 Avisi Technologies LLC Company Overview 25

5.4.1 Avisi Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 25

5.5 Chongqing Migos Medical Technology Co Ltd Company Overview 26

5.5.1 Chongqing Migos Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 26

5.6 Ciliatech Therapeutics AG Company Overview 27

5.6.1 Ciliatech Therapeutics AG Pipeline Products & Ongoing Clinical Trials Overview 27

5.7 Corneat Vision Ltd Company Overview 31

5.7.1 Corneat Vision Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

5.8 Eye Sonix Company Overview 32

5.8.1 Eye Sonix Pipeline Products & Ongoing Clinical Trials Overview 32

5.9 Galaxy Ophthalmics Inc (Inactive) Company Overview 33

5.9.1 Galaxy Ophthalmics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 33

5.10 Geuder AG Company Overview 34

5.10.1 Geuder AG Pipeline Products & Ongoing Clinical Trials Overview 34

5.11 Glaucot Teknoloji AS Company Overview 35

5.11.1 Glaucot Teknoloji AS Pipeline Products & Ongoing Clinical Trials Overview 35

5.12 Glaukos Corp Company Overview 38

5.12.1 Glaukos Corp Pipeline Products & Ongoing Clinical Trials Overview 38

5.13 HiSilicon (Suzhou) Biomedical Technology Co Ltd Company Overview 39

5.13.1 HiSilicon (Suzhou) Biomedical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

5.14 Iantrek Inc Company Overview 41

5.14.1 Iantrek Inc Pipeline Products & Ongoing Clinical Trials Overview 41

5.15 InjectSense Inc Company Overview 44

5.15.1 InjectSense Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.16 InnFocus Inc Company Overview 45

5.16.1 InnFocus Inc Pipeline Products & Ongoing Clinical Trials Overview 45

5.17 iScience Interventional Inc Company Overview 48

5.17.1 iScience Interventional Inc Pipeline Products & Ongoing Clinical Trials Overview 48

5.18 iSTAR Medical SA Company Overview 49

5.18.1 iSTAR Medical SA Pipeline Products & Ongoing Clinical Trials Overview 49

5.19 iVeena Delivery Systems Inc Company Overview 55

5.19.1 iVeena Delivery Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 55

5.20 Johns Hopkins University Company Overview 56

5.20.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 56

5.21 Kytogenics Pharmaceuticals Inc Company Overview 57

5.21.1 Kytogenics Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 57

5.22 Liqid Medical (Pty) Ltd Company Overview 58

5.22.1 Liqid Medical (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview 58

5.23 Medtronic Plc Company Overview 63

5.23.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 63

5.24 Meir Medical Center Company Overview 64

5.24.1 Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview 64

5.25 Merz Anteis SA Company Overview 65

5.25.1 Merz Anteis SA Pipeline Products & Ongoing Clinical Trials Overview 65

5.26 MicroOptx Inc Company Overview 66

5.26.1 MicroOptx Inc Pipeline Products & Ongoing Clinical Trials Overview 66

5.27 Mingche Biotechnology (Suzhou) Co Ltd Company Overview 67

5.27.1 Mingche Biotechnology (Suzhou) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 67

5.28 Myra Vision Inc Company Overview 68

5.28.1 Myra Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 68

5.29 Ocumatrx Company Overview 71

5.29.1 Ocumatrx Pipeline Products & Ongoing Clinical Trials Overview 71

5.30 OcuTherix Inc Company Overview 72

5.30.1 OcuTherix Inc Pipeline Products & Ongoing Clinical Trials Overview 72

5.31 OPKO Health Inc Company Overview 73

5.31.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 73

5.32 OptoLight Vision Technology Company Overview 74

5.32.1 OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview 74

5.33 Purdue University Company Overview 75

5.33.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 75

5.34 Queen’s University Company Overview 76

5.34.1 Queen’s University Pipeline Products & Ongoing Clinical Trials Overview 76

5.35 Rheon Medical SA Company Overview 77

5.35.1 Rheon Medical SA Pipeline Products & Ongoing Clinical Trials Overview 77

5.36 Sight Sciences Inc Company Overview 80

5.36.1 Sight Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 80

5.37 Tel Aviv University Company Overview 82

5.37.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 82

5.38 The Chaim Sheba Medical Center Company Overview 84

5.38.1 The Chaim Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 84

5.39 University of Colorado Company Overview 85

5.39.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 85

5.40 University of Colorado Anschutz Medical Campus Company Overview 87

5.40.1 University of Colorado Anschutz Medical Campus Pipeline Products & Ongoing Clinical Trials Overview 87

5.41 University of Michigan Company Overview 88

5.41.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 88

5.42 University of Texas at Austin Company Overview 89

5.42.1 University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 89

5.43 Westhouse Medical Services Plc (Inactive) Company Overview 90

5.43.1 Westhouse Medical Services Plc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 90

6 Glaucoma Surgery Devices- Recent Developments 91

6.1 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair 91

6.2 Aug 15, 2023: Alcon Reports Second Quarter 2023 Results 91

6.3 Jul 12, 2023: Ocular Therapeutix Announces Appointment of New Board Member 96

6.4 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023 97

6.5 May 08, 2023: Ocular Therapeutix provides first quarter 2023 financial results and corporate update 97

6.6 Apr 25, 2023: OPKO Health to report Q1 2023 financial results on May 3, 2023 99

6.7 Apr 12, 2023: Medtronic has a layoff in California 100

6.8 Mar 29, 2023: STAAR Surgical Names Warren Foust Chief Operating Officer; Magda Michna, Ph.D., Chief Clinical, Regulatory and Medical Affairs Officer 100

6.9 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company 101

6.10 Feb 21, 2023: Ocular Therapeutix To Report Fourth Quarter and Year-End 2022 Financial Results 101

6.11 Feb 16, 2023: OPKO Health to Report Fourth Quarter 2022 Financial Results on February 23, 2023 101

6.12 Feb 01, 2023: Glaukos to Release Fourth Quarter and Full Year 2022 Financial Results after Market Close on February 22 102

6.13 Jan 09, 2023: STAAR Surgical Reports Preliminary Sales for Fourth Quarter and Fiscal 2022 102

6.14 Jan 09, 2023: New high-tech startup developing smart contact lenses for glaucoma diagnosis and management 103

6.15 Jan 04, 2023: Verana Health and Sight Sciences collaborate on glaucoma research using curated real-world data from the IRIS registry 104

6.16 Dec 21, 2022: Wilmington Eye ophthalmic surgeon implants first-ever glaucoma device in the Carolinas 105

6.17 Nov 23, 2022: Medtronic Reports Quarterly Earnings 106

6.18 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results 106

6.19 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday 112

6.20 Nov 15, 2022: ViaLase Strengthens Executive Team with the Appointments of Tom Frinzi as Executive Chairman of the Board Richard Lewis M.D. as Chief Medical Officer and Shawn O’Neil as Chief Commercial Officer 112

6.21 Nov 08, 2022: Zhaoke Ophthalmology : Reaching exclusive distribution agreement to commercialize TONO-i in greater China for self-measurement of intraocular pressure 113

6.22 Oct 24, 2022: Ocular Therapeutix To Report Third Quarter 2022 Financial Results 113

6.23 Sep 28, 2022: Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2022 American Academy of Ophthalmology Annual Meeting 114

6.24 Sep 22, 2022: Ocular Therapeutix To Present Data at the American Academy of Ophthalmology 2022 Annual Meeting 115

7 Appendix 118

7.1 Methodology 118

7.2 About GlobalData 121

7.3 Contact Us 121

7.4 Disclaimer 121

Table

Glaucoma Surgery Devices – Pipeline Products by Stage of Development 12

Glaucoma Surgery Devices – Pipeline Products by Segment 13

Glaucoma Surgery Devices – Pipeline Products by Territory 14

Glaucoma Surgery Devices – Pipeline Products by Regulatory Path 15

Glaucoma Surgery Devices – Pipeline Products by Estimated Approval Date 16

Glaucoma Surgery Devices – Ongoing Clinical Trials 17

Glaucoma Surgery Devices Companies – Pipeline Products by Stage of Development 18

Glaucoma Surgery Devices – Pipeline Products by Stage of Development 20

Alievio Inc Pipeline Products & Ongoing Clinical Trials Overview 22

Sollevio – Product Status 22

Sollevio – Product Description 22

Allergan Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

XEN Gel Stent – ab externo – Product Status 23

XEN Gel Stent – ab externo – Product Description 23

Assenti, LLC Pipeline Products & Ongoing Clinical Trials Overview 24

Intraocular Pressure Monitoring System – Product Status 24

Intraocular Pressure Monitoring System – Product Description 24

Avisi Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 25

VisiPlate – Product Status 25

VisiPlate – Product Description 25

Chongqing Migos Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 26

Glaucoma Surgery Device – Product Status 26

Glaucoma Surgery Device – Product Description 26

Ciliatech Therapeutics AG Pipeline Products & Ongoing Clinical Trials Overview 27

Cilio-Scleral Inter-Positioning Device – Product Status 27

Cilio-Scleral Inter-Positioning Device – Product Description 27

Ciliatech Therapeutics AG – Ongoing Clinical Trials Overview 28

Cilio-Scleral Inter-Positioning Device – Monocentre, Observational Clinical Study Evaluating the Efficacy and Safety of a Novel Interposition Supraciliary Implant in Glaucoma Surgery 29

Cilio-Scleral Inter-Positioning Device – Multicentre, Non-randomised Clinical Study Evaluating the Efficacy and Safety of Cilioscleral Interposition Device v2.2 in Glaucoma Surgery 29

Cilio-Scleral Inter-Positioning Device – Non Randomised Mono-centered Study to Evaluate Safety and Efficacy of a Novel Cilioscleral Interposition Device (CID) SV22 in Glaucoma Patients Refractory to Topical Therapy 29

Cilio-Scleral Inter-Positioning Device – Non Randomized Mono-centered Study to Evaluate Safety and Efficacy of a Novel Interposition Supraciliary Implant in Glaucoma Patients Refractory to Topical Therapy 30

Corneat Vision Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

CorNeat eShunt – Product Status 31

CorNeat eShunt – Product Description 31

Eye Sonix Pipeline Products & Ongoing Clinical Trials Overview 32

Therapeutic Ultrasound Device – Glaucoma – Product Status 32

Therapeutic Ultrasound Device – Glaucoma – Product Description 32

Galaxy Ophthalmics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 33

Titan Shunt – Product Status 33

Titan Shunt – Product Description 33

Geuder AG Pipeline Products & Ongoing Clinical Trials Overview 34

Microsystem Implant – Product Status 34

Microsystem Implant – Product Description 34

Glaucot Teknoloji AS Pipeline Products & Ongoing Clinical Trials Overview 35

GlaucoT – Product Status 35

GlaucoT – Product Description 35

Glaucot Teknoloji AS – Ongoing Clinical Trials Overview 36

GlaucoT – Pilot Study to Evaluate Clinically the Short-Term Efficacy of GlaucoT Glaucoma Treatment Glasses in the Treatment of Primary Open-Angle Glaucoma (GlaucoT) 37

Glaukos Corp Pipeline Products & Ongoing Clinical Trials Overview 38

iStent SA Trabecular Micro-Bypass System – Product Status 38

iStent SA Trabecular Micro-Bypass System – Product Description 38

HiSilicon (Suzhou) Biomedical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

MicroCOGO – Product Status 39

MicroCOGO – Product Description 39

PassCOGO – Product Status 40

PassCOGO – Product Description 40

Iantrek Inc Pipeline Products & Ongoing Clinical Trials Overview 41

CycloPen Cyclodialysis System – Product Status 41

CycloPen Cyclodialysis System – Product Description 41

Iantrek Inc – Ongoing Clinical Trials Overview 42

CycloPen Cyclodialysis System – An Observational Registry Study of Safety and Effectiveness Outcomes Through 24 Months Postoperatively Following CycloPen™ Micro-Interventional Cyclodialysis System Procedures in Patients With Open Angle Glaucoma 43

InjectSense Inc Pipeline Products & Ongoing Clinical Trials Overview 44

iOP-Connect System – Product Status 44

iOP-Connect System – Product Description 44

InnFocus Inc Pipeline Products & Ongoing Clinical Trials Overview 45

PreserFlo MicroShunt – Product Status 45

PreserFlo MicroShunt – Product Description 45

InnFocus Inc – Ongoing Clinical Trials Overview 46

PreserFlo MicroShunt – Evaluation of Minimal Invasive Glaucoma Surgery: Trabeculectomy Vs. Xen Vs. Preserflo Randomized Clinial Trial 47

PreserFlo MicroShunt – Intraocular Pressure after Preserflo /Innfocus Microshunt Vs Trabeculectomy: A Prospective, Randomized Control-trial (PAINT-Study) 47

PreserFlo MicroShunt – SIGHT study: Cost-effectiveness of InnFocus Microshunt (IMS) Implantation Versus Standard Trabeculectomy (TE) 47

iScience Interventional Inc Pipeline Products & Ongoing Clinical Trials Overview 48

Glaucoma Device – Product Status 48

Glaucoma Device – Product Description 48

iSTAR Medical SA Pipeline Products & Ongoing Clinical Trials Overview 49

MINIject – Product Status 49

MINIject – Product Description 50

STARflo MINI – Product Status 50

STARflo MINI – Product Description 50

STARflo Plus Glaucoma Implant – Product Status 51

STARflo Plus Glaucoma Implant – Product Description 51

iSTAR Medical SA – Ongoing Clinical Trials Overview 52

MINIject – A Prospective, Multicenter Masked Clinical Trial to Evaluate the Safety and Effectiveness of the MINIject CS627 Implant in Subjects with Open Angle Glaucoma 53

MINIject – A Prospective, Open, Clinical Trial Analysing the Efficacy and Safety of Miniject (MINI SO627) in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications Using a Single Operator Delivery Tool 53

MINIject – A Prospective, Open, Multicenter Clinical Trial Evaluating the Efficacy and Safety of MINIject Combined with Cataract Surgery in Patients with POAG Uncontrolled by Topical Hypotensive Medications and Operable Age-related Cataract Diagnosis 53

MINIject – A Prospective, Open, Multicenter Study Analysing the Long-term Safety of MINIject Glaucoma Implants in Patients with Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications 54

MINIject – STAR-LIFE: A Post-market Registry on MINIject 54

iVeena Delivery Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 55

IVMED-70 – Product Status 55

IVMED-70 – Product Description 55

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 56

Partially Degradable Glaucoma Stent – Product Status 56

Partially Degradable Glaucoma Stent – Product Description 56

Kytogenics Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 57

MACC-Based Device – Glaucoma Filtering – Product Status 57

MACC-Based Device – Glaucoma Filtering – Product Description 57

Liqid Medical (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview 58

iFlow – Product Status 58

iFlow – Product Description 58

iPortVR – Product Status 59

iPortVR – Product Description 59

OptiShunt V1 – Product Status 59

OptiShunt V1 – Product Description 60

OptiShunt V2 – Product Status 60

OptiShunt V2 – Product Description 60

Liqid Medical (Pty) Ltd – Ongoing Clinical Trials Overview 61

OptiShunt V1 – Glaucoma Treatment by Oculo-subarachnoid Shunt Insertion: Pilot Study 62

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 63

CellPlant Aqueous Stent – Product Status 63

CellPlant Aqueous Stent – Product Description 63

Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview 64

Glaucoma Drainage Device – Product Status 64

Glaucoma Drainage Device – Product Description 64

Merz Anteis SA Pipeline Products & Ongoing Clinical Trials Overview 65

Drainage Viscoelastic Injectable Implant – Product Status 65

Drainage Viscoelastic Injectable Implant – Product Description 65

MicroOptx Inc Pipeline Products & Ongoing Clinical Trials Overview 66

Beacon Aqueous Microshunt (BAM) – Product Status 66

Beacon Aqueous Microshunt (BAM) – Product Description 66

Mingche Biotechnology (Suzhou) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 67

Minimally Invasive Glaucoma Drainage Tube – Product Status 67

Minimally Invasive Glaucoma Drainage Tube – Product Description 67

Myra Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 68

Calibreye – Product Status 68

Calibreye – Product Description 68

Myra Vision Inc – Ongoing Clinical Trials Overview 69

Calibreye – Feasibility Clinical Evaluation of the Calibreye System 70

Ocumatrx Pipeline Products & Ongoing Clinical Trials Overview 71

CaPRI Device – Product Status 71

CaPRI Device – Product Description 71

OcuTherix Inc Pipeline Products & Ongoing Clinical Trials Overview 72

Deep Wave Trabeculoplasty Device – Product Status 72

Deep Wave Trabeculoplasty Device – Product Description 72

OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 73

Aquashunt – Product Status 73

Aquashunt – Product Description 73

OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview 74

Lipshitz Macular Implant – Advanced Glaucoma – Product Status 74

Lipshitz Macular Implant – Advanced Glaucoma – Product Description 74

Purdue University Pipeline Products & Ongoing Clinical Trials Overview 75

Smart Drainage Device – Glaucoma – Product Status 75

Smart Drainage Device – Glaucoma – Product Description 75

Queen’s University Pipeline Products & Ongoing Clinical Trials Overview 76

Laser Adjustable Suture – Product Status 76

Laser Adjustable Suture – Product Description 76

Rheon Medical SA Pipeline Products & Ongoing Clinical Trials Overview 77

eyeWatch System – Product Status 77

eyeWatch System – Product Description 77

Rheon Medical SA – Ongoing Clinical Trials Overview 78

eyeWatch System – EyeTube in Combination with the eyeWatch Implant 79

eyeWatch System – Randomized Control Trial of the eyeWatch System as a First-line Surgical Treatment of Glaucoma vs. MMC-Trabeculectomy 79

Sight Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 80

OMNI Surgical System – Canal Viscodilation – Product Status 80

OMNI Surgical System – Canal Viscodilation – Product Description 80

VISCO 360 Viscosurgical System – Primary Open Angle Glaucoma – Product Status 81

VISCO 360 Viscosurgical System – Primary Open Angle Glaucoma – Product Description 81

Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 82

Direct Laser Trabeculoplasty System – Product Status 82

Direct Laser Trabeculoplasty System – Product Description 82

Glaucoma Implant – Product Status 83

Glaucoma Implant – Product Description 83

The Chaim Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 84

Toroidal Glaucoma Drainage Device – Product Status 84

Toroidal Glaucoma Drainage Device – Product Description 84

University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 85

Aqueous Humor Micro-Bypass Shunt – Product Status 85

Aqueous Humor Micro-Bypass Shunt – Product Description 85

Glaucoma Device – Product Status 86

Glaucoma Device – Product Description 86

University of Colorado Anschutz Medical Campus Pipeline Products & Ongoing Clinical Trials Overview 87

Glaucoma Drainage Device Regulator – Product Status 87

Glaucoma Drainage Device Regulator – Product Description 87

University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 88

Integrated Magnetoelastic Actuator – Product Status 88

Integrated Magnetoelastic Actuator – Product Description 88

University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 89

Microfluidic Meshwork Implant – Product Status 89

Microfluidic Meshwork Implant – Product Description 89

Westhouse Medical Services Plc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 90

Pneumatic Trabeculoplasty System – Product Status 90

Pneumatic Trabeculoplasty System – Product Description 90

Glossary 120

Figures

Glaucoma Surgery Devices – Pipeline Products by Stage of Development 12

Glaucoma Surgery Devices – Pipeline Products by Segment 13

Glaucoma Surgery Devices – Pipeline Products by Territory 14

Glaucoma Surgery Devices – Pipeline Products by Regulatory Path 15

Glaucoma Surgery Devices – Pipeline Products by Estimated Approval Date 16

Glaucoma Surgery Devices – Ongoing Clinical Trials 17

Frequently asked questions

Glaucoma Surgery Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Glaucoma Surgery Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Glaucoma Surgery Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Glaucoma Surgery Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.